University of Twente, Department of Health Technology and Services Research, Technical Medical Centre, Enschede, the Netherlands; Santeon, Utrecht, the Netherlands.
University of Twente, Department of Psychology, Health & Technology, Enschede, the Netherlands.
Eur J Cancer. 2024 Dec;213:115107. doi: 10.1016/j.ejca.2024.115107. Epub 2024 Nov 2.
Integrating outcome information into the process of shared decision-making (SDM) about post-treatment surveillance can enhance its effectiveness. The Breast Cancer Surveillance Decision Aid (BCS-PtDA) integrates risk estimations of patients' risks for recurrences as well as outcome information on fear of cancer recurrence (FCR). The SHOUT-BC study aimed to evaluate the effectiveness of the implementation of the BCS-PtDA. Patients' satisfaction with the BCS-PtDA was also evaluated.
As described in a previously published protocol paper, the study employed a Prospective multiple interrupted time series (ITS) design in which the BCS-PtDA was implemented stepwise into the care pathways of eight Dutch hospitals.
A total of 507 participants completed a questionnaire after their first surveillance consultation which usually takes place approximately one year after surgery. ITS analysis per hospital and subsequent meta-analysis over hospital effects indicated a significant increase in patient-reported SDM from pre- to post-implementation (overall estimated effect: 27.14, 95 % CI: 22.71 to 31.87, p < .0001). Moreover, post-implementation participants (n = 225) reported a more active role in decision-making, decreased decisional conflict, and increased knowledge on the aim and methods of surveillance. Furthermore, a decrease in FCR was seen post-implementation. The self-reported intensity of surveillance schedules decreased slightly and the BCS-PtDA received highly positive evaluations.
The implementation of the BCS-PtDA, which integrates outcome information, led to increased patient-reported SDM and an improved quality of decision-making. The BCS-PtDA was evaluated highly positively by participants. Further research should address optimisation of the implementation.
将预后信息纳入治疗后监测的共同决策(SDM)过程中,可以提高其效果。乳腺癌监测决策辅助工具(BCS-PtDA)整合了患者复发风险的估计以及对癌症复发恐惧(FCR)的预后信息。SHOUT-BC 研究旨在评估 BCS-PtDA 的实施效果。同时还评估了患者对 BCS-PtDA 的满意度。
正如之前发表的方案论文所述,该研究采用前瞻性多个中断时间序列(ITS)设计,逐步将 BCS-PtDA 实施到 8 家荷兰医院的护理路径中。
共有 507 名参与者在第一次监测咨询后完成了一份问卷,第一次监测咨询通常在手术后大约一年进行。对每家医院进行 ITS 分析,并对医院间的效果进行荟萃分析,结果表明,患者报告的 SDM 从实施前到实施后有显著增加(总体估计效果:27.14,95%CI:22.71 至 31.87,p<0.0001)。此外,实施后组(n=225)报告在决策中发挥更积极的作用,决策冲突减少,对监测目的和方法的认识增加。此外,实施后 FCR 下降。自我报告的监测计划强度略有下降,BCS-PtDA 获得了高度积极的评价。
将预后信息纳入其中的 BCS-PtDA 的实施提高了患者报告的 SDM 和决策质量。参与者对 BCS-PtDA 的评价非常积极。进一步的研究应解决实施的优化问题。